Suchergebnisse - "Komers, Radko"

PubPharm (130)

1

COMBINATION THERAPY WITH SPARSENTAN AND A SGLT2 INHIBITOR FOR TREATING KIDNEY DISEASES OR DISORDERS

enthalten in: Europäisches Patentamt | 2024

von KOMERS RADKO

2

Sparsentan versus Irbesartan in Focal Segmental Glomerulosclerosis. Reply

enthalten in: The New England journal of medicine | 2024

von Trachtman, H. | Rheault, M. | Komers, R.

CommentOn: N Engl J Med. 2023 Dec 28;389(26):2436-2445. - PMID 37921461

3

Sparsentan ameliorates glomerular hypercellularity and inflammatory-gene networks induced by IgA1-IgG immune complexes in a mouse model of IgA nephropathy

enthalten in: American journal of physiology. Renal physiology | 2024

von Reily, C. | Moldoveanu, Z. | Pramparo, T. | +7

4

Sparsentan : the first and only non-immunosuppressive therapy for the reduction of proteinuria in IgA nephropathy

enthalten in: Expert review of clinical immunology | 2024

von Trachtman, H. | Komers, R. | Inrig, J.

5

Sparsentan is superior to losartan in the gddY mouse model of IgA nephropathy

enthalten in: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association | 2024

von Nagasawa, H. | Ueda, S. | Suzuki, H. | +10

6

Sparsentan versus Irbesartan in Focal Segmental Glomerulosclerosis

enthalten in: The New England journal of medicine | 2023

von Rheault, M. | Alpers, C. | Barratt, J. | +125

CommentIn: N Engl J Med. 2024 Mar 21;390(12):1153-1154. - PMID 38507767

7

Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT) : 2-year results from a randomised, active-controlled, phase 3 trial

enthalten in: Lancet (London, England) | 2023

von Rovin, B. | Barratt, J. | Heerspink, H. | +130

CommentIn: Lancet. 2023 Dec 2;402(10417):2046-2047. - PMID 37931627

8

Status of current trials and potential future trials with sparsentan

enthalten in: Expert opinion on emerging drugs | 2023

von Trachtman, H. | Komers, R. | Inrig, J.

9

Implications of Complete Proteinuria Remission at any Time in Focal Segmental Glomerulosclerosis : Sparsentan DUET Trial

enthalten in: Kidney international reports | 2023

von Trachtman, H. | Diva, U. | Murphy, E. | +3

10

Biphenyl sulfonamide compounds for the treatment of kidney diseases or disorders

enthalten in: Europäisches Patentamt | 2023

von KOMERS RADKO | SHIH ALVIN

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[13]